digital health funding
Telehealth company Caregility, hybrid cancer care company Daymark Health and virtual care company AmplifyMD also garnered funding.
The company will use the funds to expand Dreem Health, scale nationwide and advance its FDA-cleared sleep apnea technology.
The Series D funding brings the company’s total raise to $275 million and its valuation to more than $1 billion.
The company stated Capital Rx will still operate as its pharmacy benefits manager brand under Judi Health.
The company will use the funds to expand nationally, enhance its technology platform and advance clinical innovation.
The round follows a $200 million seed raise earlier this year.
The funding round comes one month after the company announced it secured a $35 million investment.
The funds will be used to expand the company's reach with payers and providers, grow its team and for product development.
The company is on track to be live in 10 U.S. states by the end of 2025.
The company will use the funding to further develop its SmartShunt System, aimed at reducing shunt failures and improving care for patients with hydrocephalus.